These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 19344413)

  • 21. Down-regulation of the HGF/MET autocrine loop induced by celecoxib and mediated by P-gp in MDR-positive human hepatocellular carcinoma cell line.
    Mazzanti R; Platini F; Bottini C; Fantappiè O; Solazzo M; Tessitore L
    Biochem Pharmacol; 2009 Jul; 78(1):21-32. PubMed ID: 19447220
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protein kinase C-alpha antagonizes apoptosis induction by histone deacetylase inhibitors in multidrug resistant leukaemia cells.
    Castro-Galache MD; Menéndez-Gutiérrez MP; Carrasco Garcia E; Garcia-Morales P; Martinez-Lacaci I; Saceda M; Ferragut JA
    Int J Biochem Cell Biol; 2007; 39(10):1877-85. PubMed ID: 17588800
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Suppression of glucosylceramide synthase by RNA interference reverses multidrug resistance in human breast cancer cells.
    Sun YL; Zhou GY; Li KN; Gao P; Zhang QH; Zhen JH; Bai YH; Zhang XF
    Neoplasma; 2006; 53(1):1-8. PubMed ID: 16416005
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overcoming multidrug resistance in human carcinoma cells by an antisense oligodeoxynucleotide--doxorubicin conjugate in vitro and in vivo.
    Ren Y; Wang Y; Zhang Y; Wei D
    Mol Pharm; 2008; 5(4):579-87. PubMed ID: 18461970
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Wnt receptor FZD1 mediates chemoresistance in neuroblastoma through activation of the Wnt/beta-catenin pathway.
    Flahaut M; Meier R; Coulon A; Nardou KA; Niggli FK; Martinet D; Beckmann JS; Joseph JM; Mühlethaler-Mottet A; Gross N
    Oncogene; 2009 Jun; 28(23):2245-56. PubMed ID: 19421142
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of apoptosis by downregulation of hBex1, a novel mechanism, contributes to the chemoresistance of Bcr/Abl+ leukemic cells.
    Ding K; Su Y; Pang L; Lu Q; Wang Z; Zhang S; Zheng S; Mao J; Zhu Y
    Carcinogenesis; 2009 Jan; 30(1):35-42. PubMed ID: 19028701
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ABCB1 over-expression and drug-efflux in acute lymphoblastic leukemia cell lines with t(17;19) and E2A-HLF expression.
    Baudis M; Prima V; Tung YH; Hunger SP
    Pediatr Blood Cancer; 2006 Nov; 47(6):757-64. PubMed ID: 16206189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-tumour effects of HL-37, a novel anthracene derivative, in-vivo and in-vitro.
    Xie SQ; Hu GQ; Zhang ZQ; Xu M; Ji BS
    J Pharm Pharmacol; 2008 Feb; 60(2):213-9. PubMed ID: 18237469
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chinese herbs of Shenghe Powder reverse multidrug resistance of gastric carcinoma SGC-7901.
    Wang J; Xia Y; Wang H; Hou Z
    Integr Cancer Ther; 2007 Dec; 6(4):400-4. PubMed ID: 18048888
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methylation-controlled J protein promotes c-Jun degradation to prevent ABCB1 transporter expression.
    Hatle KM; Neveu W; Dienz O; Rymarchyk S; Barrantes R; Hale S; Farley N; Lounsbury KM; Bond JP; Taatjes D; Rincón M
    Mol Cell Biol; 2007 Apr; 27(8):2952-66. PubMed ID: 17283040
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prediction of broad spectrum resistance of tumors towards anticancer drugs.
    Efferth T; Konkimalla VB; Wang YF; Sauerbrey A; Meinhardt S; Zintl F; Mattern J; Volm M
    Clin Cancer Res; 2008 Apr; 14(8):2405-12. PubMed ID: 18413831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Growth factor-independent 1B gene (GFI1B) is overexpressed in erythropoietic and megakaryocytic malignancies and increases their proliferation rate.
    Elmaagacli AH; Koldehoff M; Zakrzewski JL; Steckel NK; Ottinger H; Beelen DW
    Br J Haematol; 2007 Jan; 136(2):212-9. PubMed ID: 17156408
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glucocorticoid sensitisation in Mixed Lineage Leukaemia-rearranged acute lymphoblastic leukaemia by the pan-BCL-2 family inhibitors gossypol and AT-101.
    Spijkers-Hagelstein JA; Schneider P; Pinhanços SM; Garrido Castro P; Pieters R; Stam RW
    Eur J Cancer; 2014 Jun; 50(9):1665-74. PubMed ID: 24703900
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibit multidrug resistance and induce apoptosis by using glycocholic acid and epirubicin.
    Lo YL; Ho CT; Tsai FL
    Eur J Pharm Sci; 2008 Sep; 35(1-2):52-67. PubMed ID: 18606222
    [TBL] [Abstract][Full Text] [Related]  

  • 35. N,N-dimethyl phytosphingosine induces caspase-8-dependent cytochrome c release and apoptosis through ROS generation in human leukemia cells.
    Kim BM; Choi YJ; Han Y; Yun YS; Hong SH
    Toxicol Appl Pharmacol; 2009 Aug; 239(1):87-97. PubMed ID: 19481559
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting of Bcl-2 family proteins for treatment of acute leukaemia.
    Jurečeková J; Hatok J; Stefániková A; Dobrota D; Račay P
    Gen Physiol Biophys; 2011; 30 Spec No():S3-S12. PubMed ID: 21869449
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RAIDD expression is impaired in multidrug resistant osteosarcoma cell lines.
    Yang C; Hornicek FJ; Wood KB; Schwab JH; Mankin H; Duan Z
    Cancer Chemother Pharmacol; 2009 Aug; 64(3):607-14. PubMed ID: 19125251
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trichostatin A sensitizes human ovarian cancer cells to TRAIL-induced apoptosis by down-regulation of c-FLIPL via inhibition of EGFR pathway.
    Park SJ; Kim MJ; Kim HB; Sohn HY; Bae JH; Kang CD; Kim SH
    Biochem Pharmacol; 2009 Apr; 77(8):1328-36. PubMed ID: 19426671
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Emodin sensitizes paclitaxel-resistant human ovarian cancer cells to paclitaxel-induced apoptosis in vitro.
    Li J; Liu P; Mao H; Wanga A; Zhang X
    Oncol Rep; 2009 Jun; 21(6):1605-10. PubMed ID: 19424643
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nanoparticle-mediated combination chemotherapy and photodynamic therapy overcomes tumor drug resistance in vitro.
    Khdair A; Handa H; Mao G; Panyam J
    Eur J Pharm Biopharm; 2009 Feb; 71(2):214-22. PubMed ID: 18796331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.